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Abstract
Major outer membrane proteins (MOMPs) of Gram negative bacteria are one of the most intensively studied membrane
proteins. MOMPs are essential for maintaining the structural integrity of bacterial outer membranes and in adaptation of
parasites to their hosts. There is evidence to suggest a role for purified MOMP from Chlamydophila pneumoniae and
corresponding MOMP-derived peptides in immune-modulation, leading to a reduced atherosclerotic phenotype in apoE2/2
mice via a characteristic dampening of MHC class II activity. The work reported herein tests this hypothesis by employing a
combination of homology modelling and docking to examine the detailed molecular interactions that may be responsible.
A three-dimensional homology model of the C. pneumoniae MOMP was constructed based on the 14 transmembrane b-
barrel crystal structure of the fatty acid transporter from Escherichia coli, which provides a plausible transport mechanism for
MOMP. Ligand docking experiments were used to provide details of the possible molecular interactions driving the binding
of MOMP-derived peptides to MHC class II alleles known to be strongly associated with inflammation. The docking
experiments were corroborated by predictions from conventional immuno-informatic algorithms. This work supports
further the use of MOMP in C. pneumoniae as a possible vaccine target and the role of MOMP-derived peptides as vaccine
candidates for immune-therapy in chronic inflammation that can result in cardiovascular events.
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Introduction
Chlamydophila pneumoniae is an obligate Gram negative bacterium
responsible for approximately 20% of community acquired lower
respiratory disease [1] and for at least 10% of community acquired
pneumonia [2,3]. The Gram negative bacterium, belonging to the
genus Chlamydophila, includes other members of the genus such as
C. psittaci and C. trachomatis, all of which are responsible for human
infections. C. pneumoniae infections are also associated with
bronchitis, sinusitis and other acute and chronic inflammatory
diseases such as atherosclerosis [4]. Atherosclerosis is a chronic
multifactorial inflammatory disease including genetic and envi-
ronmental factors and long-term bystander inflammation by
pathogenic microorganisms such Cytomegalovirus and Herpes virus
[5]. This association has been confirmed by studies on the
immune-histochemical properties and DNA fingerprinting studies
on atherosclerotic plaques both in human and animal models of
the disease [6,7]. Some results have shown the repeated presence
of Chlamydophila pneumoniae footprints in atherosclerotic tissues and
a near to absence in adjoining normal tissues. It has been
suggested that Chlamydophila pneumoniae potentiates inflammation/
development of atherosclerosis by at least one of the following
mechanisms; induction of matrix metalloproteinases [8], induction
of macrophages to secrete adhesion molecules, cytokines [9,10],
enhancing oxidative remodelling of low density lipoprotein [9] and
calcification of atherosclerotic plaques [11]. We have recently
suggested another mechanism which involves the dampening of
anti-Chlamydophila antibody and T cell responses [12].
Gram negative bacteria are characterised by their possession of
two lipid bilayer membranes separated by a periplasmic layer. The
outer membrane of Gram negative bacteria has an additional
layer of lipopolysaccharide. This membrane system is a defensive
barrier against the diffusion of lipophilic or otherwise hydrophilic
xenobiotics, which may pose danger to the survival of the bacteria
[13]. To enhance the uptake of solutes from the extracellular
environment, Gram negative bacteria have evolved outer mem-
brane proteins (OMP) for this purpose. In Chlamydophila pneumoniae,
the majority of outer membrane protein present is a 40 kDa
protein constituting about 60% of the total mass of its outer
membrane and hence it is referred to as the major outer
membrane protein (MOMP) [14,15]. MOMP, in the genus
Chlamydophila, is relatively conserved and typified by several
cysteine residues. These cysteine residues contribute to the
formation of disulphide bridges which act to stabilise the
membrane integrity mainly in elementary bodies. Typical of most
outer membrane proteins of Gram negative bacteria, these form b-
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barrel structures in the outer membrane in a fashion identical to
their orthologs in the mitochondria and choloroplasts [16,17]. The
importance of the transmembrane b-barrel is exemplified by the
fact that approximately 2–3% of the genome of Gram negative
bacteria encode for this class of protein [18]. However, at the time
of writing this paper, of the 80, 550 non-redundant protein
structures in the Protein Data Bank (www.pdb.org) only 308
(http://blanco.biomol.uci.edu/mpstruc/listAll/list) represent
membrane protein structures and of these only 125 are
represented by b-barrel folds. This gap is a result of the
tremendous challenges that continue to accompany structure
determination of membrane protein structures. Therefore, in silico
prediction of three-dimensional structure remains a valuable tool
for understanding the role of these proteins in biology and
medicine.
Preliminary evidence suggests that the purified MOMP of
Chlamydophila pneumoniae has anti-atherosclerotic and anti-inflam-
matory effects [12,19–21]. This mechanism could potentially
favour Chlamydophila’s survival within macrophages while
keeping a slow chronic induction of inflammation within
atherosclerotic plaques contributing to their development over
many years. These results also point to the involvement of MHC
class II peptide regulation of inflammation-linked to atherosclero-
sis development in an apoE2/2 mice model. As such, MHC class
II peptides represent potential vaccine candidates for the design of
an anti-atherosclerosis vaccine.
Molecular modelling of peptide-MHC complexes provides an
insight into the detailed interactions stabilising these complexes.
Such methods rely on empirical algorithms for the prediction of
the orientation of the peptides and subsequent binding affinity for
specificity pockets within the binding site [22,23]. The complexity
of molecular docking approaches range from rigid body docking to
flexible docking of ligands to their receptors. The computational
results provided by these techniques can provide useful informa-
tion regarding the most promising candidates for further
investigation and can be an important factor in early elimination
of poor lead candidates.
Herein we show, in silico algorithms used to construct the first
three dimensional homology model of MOMP from Chlamydophila
pneumoniae that may support previously formulated hypothesis on
its mechanism of action and the potential molecular interactions of
MOMP-derived peptides bound to MHC class II receptors. The
data presented in this work provides new insights into further
understanding of the role of MOMP and MOMP-derived peptides
in the pathogenesis of inflammatory diseases.
Materials and Methods
All calculations and analyses were performed using a Windows
7 Enterprise operating system; AMD PhenomTMII X6 1045T
Processor 2.70 GHz, and 4.00 GB RAM memory. Unless
otherwise stated, all other figures were prepared using PyMOL
[24].
Sequence Analysis
Blastp was used to find the homologs of MOMP and multiple
sequence alignments were performed using ClustalW [25], using
default settings and resulting sequence identities (%) and
similarities (%) were calculated manually. Phylogenetic plots were
rendered using TreeView [26].
Homology Modelling
Two template-based structure prediction methods were em-
ployed, Phyre [27] and IntFold [28], in the search for a suitable
homology model template for MOMP. Amino acid sequences for
the chosen template (P10384 and P77697 for the fatty acid
transporter protein) and the target (P27455, Q6LDD2 and
Q9JQF6 for MOMP) were obtained from UniProt [29].
MODELLER [30] was used to build a homology model of
MOMP, based on the 2.60 A˚ resolution fatty acid transporter
crystal structure, as suggested by IntFold. Any bound ligands in the
crystal structure of the template, such as lauryl dimethylamine-n-
oxide, (hydroxyethyloxy)tri(ethyloxy)octane and copper ions, were
removed during modelling.
Statistical Analysis and Validation of MOMP Homology
Models
All homology models were analysed for optimal geometric
characteristics using Procheck [31], What_Check [32], Verify 3D
[33,34], Errat [35] and Prove [36] found at the SAVeS server
(http://nihserver.mbi.ucla.edu/SAVES/). RMSDs between the
model and the template were calculated by TM-align [37] and
selection of the final model was made based on comparison of
optimal geometric characteristics and agreement with secondary
structure predictions, as rendered by TMBB-DB [38].
Flexible Molecular Docking
Docking experiments were conducted to probe the interactions
between four MOMP-derived 15-mer novel peptides and the
MHC class II family of antibodies, specifically I-Ab and HLA
DRB1*0401, two alleles strongly linked to inflammatory diseases.
The four MOMP-derived peptides (Table 1) were derived using
epitope prediction algorithms[39–43] capable of predicting MHC
class II restricted peptides, based on the MOMP sequence, and
assessed for their ability to be recognised by murine MHC class II
molecules. Each of the four peptides were modelled using the
Biopolymer application as provided by the software package
Sybyl-X 1.3 as b-strands, hydrogens were added in idealised
geometry and subsequent minimisation of bond torsion as well as
whole molecule was performed using the conjugate gradient
algorithm [44]. Two MHC protein structures were retrieved from
the Protein Data Bank (PBD codes 1MUJ and 2SEB). IMUJ (I-Ab)
is the mouse MHC protein complexed with a Class II-associated
invariant chain peptide (CLIP), while 2SEB (HLA DRB1*0401)
represents the human allele protein bound to a peptide fragment
of human collagen II. Non-protein moieties, such as water and N-
acetyl glucosamine, were removed prior to docking and hydrogens
were added in idealised geometries. Protomol generation and
definition of the ligand binding groove was performed using a
ligand directed method, which allows the docking of ligands into
predefined sites as defined by occupancy of co-crystallised ligands.
An overall energy minimisation of each MHC was performed
using the Tripos force field [45] and employing a conjugate
gradient algorithm [44] with a convergence criterion of 0.05 kcal/
mol A21.
Docking studies were performed using the program Surflex-
Dock (SFXC, [46]) as provided by Sybyl-X 1.3. Independent
docking runs were performed for each of the four peptides against
each of the two MHC II protein targets. The Surflex-X docking
algorithm docks a given ligand to a receptor using a flexible ligand
and a semi-flexible receptor; in this case the peptides were allowed
to be fully flexible while the receptor was semi-flexible. This allows
for optimisation of potentially favourable molecular interactions,
such as those defined by hydrogen bond and van der Waal forces.
The docking results yield a docking score, which takes into
consideration entropic, polar, hydrophobic, repulsive and desolva-
tion factors. The score is expressed as total docking score defined
by –log10Kd, where Kd is the dissociation constant. The free
Transport Mechanism from MOMP in Chlamydophila
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energy of binding of the ligand to the protein was extrapolated
from equation (1).
Free energy of binding~RTlogeKd ð1Þ
The molecular interactions of the docked peptides were
analysed by CONTACTS, as provided in the CCP4 suite of
programs [47]. The MOLCAD module, as provided within Sybyl-
X 1.3 program, was used for identification of the surface
characteristics (electrostatic, lipophilic) in the binding groove of
the target protein.
Validation of the Docking Procedure
To validate the accuracy of the docking procedure, the original
peptide ligands (and all ligands) were removed from the structure
file and subsequently docked into the corresponding crystal
structure of the MHC proteins, but not using a ligand-directed
approach. The resulting ‘‘freely docked’’ (i.e. assuming no prior
orientation in the receptor MHC) peptide-MHC complexes were
compared to the original peptide-MHC complex, as seen in the
original crystal structure of the complex. In this way, the method
was validated for its reliability to reproduce essential molecular
interactions. Comparative structural orientation of the peptide was
calculated as an RSMD between the docked peptide and the
original peptide as found in the crystal structure, using TM-align
[37].
Prediction of Peptide-MHC Class II Binding
The binding mode of each peptide was predicted using
immuno-informatics prediction servers. Each 15-mer peptide
was submitted to the following servers, using default parameters:
NetMHC IIpan [48], SMM align [49], NN align [40], Sturnolio
[50], RANKPEP [51], MHC2PRED (http://www.imtech.res.in/
raghava/mhc2pred/), PROPRED [42], and SVMHC [52] and
analysed to derive a consensus nonamer for the binding core.
Results
Sequence Analysis
In an effort to identify suitable homologs of MOMP for
homology modelling, a BlastP search was performed using the
NCBI databases (http://www.ncbi.nlm.nih.gov/blast/). The
search revealed that MOMP had very high sequence identity to
other Chlamydophila MOMP sequences whose three dimensional
structure have yet to be resolved (Figure 1). The NPS motif,
located five amino acids from the N-terminus of the mature
MOMP protein from C. pneumonia, is substituted by NPA in every
other Chlamydophila species. A second NPS motif, 294 amino acid
positions from the N-terminus, is replaced by an NPT motif in all
Chlamydophila species except C.caviae and C.felis, which show
deletions in the corresponding regions. However, the NPA at
position 82 is conserved in C.muridarom, C.trachomatis and C.pecurom.
Additionally, the proline residue, in the second position of the
NPA motif of MOMP, is substituted by phenylalanine and
isoleucine in C. psittaci and C.abortus, respectively. Phylogenetic
analysis reveals that among the genus Chlamydophila, MOMP from
C. pneumoniae is more closely related to those of C. psittaci and C.
abortus (Figure S1). This is reflected also in the higher sequence
identity of 75% and 76%, respectively, as compared to MOMPs
from the other species (Figure 1).
Interestingly, a standard Blastp search did not identify non-
Chlamydophila homologs of known structure exhibiting a b-barrel
fold expected for MOMP [53]. The top ranking non-Chlamydophila
homolog identified by the search was the resuscitation promoting
factor RpfB (PDB codes 3EO5, 1XSF) from Mycobacterium
tuberculosis sharing 41% identity with MOMP, which shows a
multi-domain structure more characteristic of cell adhesion
proteins. This result did not suggest consistency with the known
physico-chemical properties of MOMP and indeed other outer
membrane proteins from Chlamydophila.
As an alternative approach, structure based template prediction
methods were utilised (IntFold and Phyre) to identify suitable
structural homology templates. Sequences of predicted templates
were screened by comparative analysis of MOMP, using
ClustalW. Guided by the two NPS motifs and one NPA motif in
MOMP, and the overall sequence identity to the predicted
templates, selection of a final structural template for modelling was
made. The NPA and NPS motifs are common to aquaporins and
bacterial fatty acid transporters. The phylogenetic analysis of
Chlamydophila MOMP with bacterial fatty acid transporters,
aquaporins and aquaglyceroporins, as performed herein, shows
the uniqueness of MOMP and its unanticipated relatedness to
non-prokaryotic NPA motif bearing proteins (Figure S1).
Homology Modelling
The structure based template method Phyre produced two
possible template structures, PDB codes 2X27 and 2F1T,
corresponding to OM Oprg from Pseudomonas aeruginosa and
OmpW from Escherichia coli, respectively. Both 2X27 and 2F1T
exhibit an 8-stranded b-barrel structure but share less than 15%
identity and, only 34.3% and 26.4% sequence similarity,
respectively, compared with the MOMP sequence. A structural
template for MOMP was found by IntFold, based on the crystal
structure of the fatty acid transporter FadL from Escherichia coli
(PBD code 1T16). In this case, the sequence identity was 16.9%
and the sequence similarity was 39.6%. This fatty acid transporter
has an NPA motif within the first 30 residues of its primary
structure, analogous to MOMP.
Both stereochemical and knowledgebase approaches were used
to select and validate the template models, as revealed by Phyre
and Intfold. First, each model was evaluated for stereochemical
Table 1. Analysis of the physico-chemical properties of four novel MOMP-derived peptides.
Peptide Sequence
Grand average
hydropathy (GRAVY) Aliphatic index
Average
hydro-philicity
% hydrophilic residue
composition
MdP1 DPSLLIDGTIWEGAA 0.327 117.330 20.2 27
MdP2 KLLKSALLSAAFAGS 0.973 130.670 20.3 33
MdP3 SLSYRLNSLVPYIGV 0.620 142.670 20.7 33
MdP4 DNIRIAQPKLPTAVL 0.107 136.670 0.0 33
doi:10.1371/journal.pone.0061139.t001
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fitness by PROCHECK. Second, information regarding the
availability of the variable segments of a MOMP homolog (from
C. trachomatis) to proteolysis by trypsin was used as a guide to
select an appropriate model [54]. And third, coordination in the
location of the NPA motif and two NPS motifs of MOMP were
utilised to reveal a plausible transport model. The final MOMP
model (Figure 2), derived using MODELLER, reveals a 14 b-
barrel protein with an external a-helix and a putative ‘hatch’
domain. The model indicates putative locations of the four
variable domains and of the numerous cysteine residues. The
resulting model provides a plausible transport model for
Chlamydophila MOMP (Figure 3).
The final MOMP model yields favourable restraints in bond
distances and dihedral angles, according to PROCHECK [31]
with 87.2% of its residues favoured, 11.0% allowed, 1.3%
generously allowed and 0.6% disallowed; G-factor of 20.5, and
main chain bond length and angles of 96% and 86.4%,
respectively. Assessment of the model for structural similarity,
compared with the template, reveals an RMSD of 1.86 A˚. The
RMSD value corresponds to the geometric changes in the three
dimensional structure between the model (MOMP) and the
template (FadL).
Comparison of Template MHC Alleles
Murine MHC I-Ab (PDB Code: 1MUJ) and its human ortholog
(PDB Code: 2SEB) were used for the docking experiments. The
MHC II proteins share a sequence identity of 56.4% and 78.8%
similarity for the a-chain and, 64.6% identity and 84.1% similarity
for the b-chain. Figure 4 shows the superposition of the two MHC
II target proteins of interest sharing a structural identity of 1.24 A˚.
Similarly, the four most important hydrophobic pockets (labelled
1, 4, 6 and 9, Figure 4) reveal high sequence and structural
similarity in amino acid composition and spatial orientation.
Pocket 1 is the most highly conserved pocket between both alleles
and largely dominated by aromatic amino acids of the a-chain.
The aI31 in the human allele is substituted by leucine in the same
position in the mouse allele. In contrast to pocket 1, pocket 4 is
predominantly formed by the b-chain and has a very low amino
acid identity between the two alleles. However, in each allele
pocket 4 reveals a predominance of hydrophobic amino acids such
as tyrosine, phenylalanine and valine. Negatively charged bD28,
in the human allele, is substituted by a polar uncharged threonine
residue in the mouse allele, whereas, human bA74 is occupied by a
negatively charged glutamic acid residue in the mouse allele. More
importantly, pocket 4 of the human allele possesses an autoim-
mune epitope 67LLEGKRAA74, occupied by 67ILERTRAE74 in
the murine allele. The composition of pocket 6 is similar to that
found in pocket 4; two negatively charged residues aE11 and
aD66 are replaced by serine and valine, respectively. Pocket 9
appears to be the second most highly conserved pocket between
the two alleles. There are substitutions of aA68 in the human allele
for a positively charged histidine in the mouse allele and similarly,
negatively charged bE9 in the human protein is substituted by
tyrosine in the mouse protein. Taken together, there is higher
hydrophobic character in pockets 1 and 9 than pockets 4 and 6,
which appear to be mixed polar/non-polar in character.
Molecular Docking MOMP-derived Peptides to MHC II
Prior to the docking study of the novel MOMP-derived
peptides, as validation of the docking procedure, coordinates of
each of the known, bound peptides were extracted from the
corresponding crystal structures (PDB Code: 1MUJ and 2SEB)
and each were docked independently back into their respective
MHC II target structures, without prior knowledge of the ligand
binding site. In each case, the docked peptide was found bound to
the target protein in a similar manner to the actual co-crystallised
structure. For each peptide, the bound geometry was evaluated
using calculated RMSD values between the docked ligand and the
corresponding bound crystallographic structure. The resulting
RMSDs were 0.97 A˚ and 0.51 A˚ for each of the two peptides
extracted and docked into 1MUJ and 2SEB target structures,
respectively (see Figure 5).
Molecular docking of four novel MOMP-derived peptides,
postulated to exhibit anti-inflammatory activity against select
MHC II targets, namely, mouse MHC class II I-Ab (PDB code:
1MUJ) and its human equivalent HLA-DR4 (PDB code: 2SEB),
was performed in an effort to assess the specificity and mode of
action of these peptides. The docked poses of each peptide are
shown in Figures 6 and 7, for the mouse and human MHC II
targets, respectively. The docking offers an explanation for
participation of both electrostatic and hydrophobic forces driving
the binding of these peptides to the MHC receptors. Consistent
with the available literature, the electrostatic interaction is between
the a-helices of the MHC and the backbone of the peptides.
Among numerous interactions hydrogen bonds were identified to
be consistent between residues of the peptides and aS53, aD55,
aQ61, aR76, aN69 and bD57, bW61, bR70 and bE74 for 1MUJ.
Residues aN62, aE55 and bK71, bH81 make hydrogen bond
contacts with peptides docked onto HLA DR4. The side chains
occupy solvent accessible pockets of the MHC with their aliphatic
side chains. Aliphatic indices of the peptides shown in Table 1
shows close correlation with the number of van der Waal
interactions in the hydrophobic pockets. These pockets are
characterised by a clustering of hydrophobic residues which
coordinate the orientation of peptide epitopes. Analysis of the
molecular interactions between the peptides and the MHCs, as
calculated using the programme CONTACTS, is provided in
Tables S1 and S2. In general, there are more extensive
interactions between these peptides and I-Ab than those observed
in the HLA DR4 complexes. Analysis of the binding core of the
peptides is complemented by online prediction using conventional
immuno-informatic algorithms (Tables S3 and S4).
Prediction of Peptide Binding Patterns
The binding pattern required to elicit an immune response via
MHCs are well documented, therefore, a variety of prediction
tools were used to determine the likely binding mode of each
peptide sequence docked onto each of the two MHC receptors
selected, using matrix or support vector based algorithms. In the
first instance, the prediction accuracy of these tools was validated
using the experimentally determined structures. These predictions
are based on empirical results rendering a prediction of a 9-mer
core binding peptide from the 15-mer peptide submitted. All
except RANKPEP gives a single prediction of the most favoured
binding core (refer to methods section for the list of other
Figure 1. Multiple sequence alignment. ClustalW alignment of the protein sequences of the major outer membrane protein (MOMP) from C.
pneumoniae and members of the genus Chlamydophila. The solid boxes show the motifs putatively involved in substrate transport and selection. The
pairwise percentage identity, to MOMP from C. pneumoniae, is indicated in parenthesis for each sequence. The dashed boxes show the four MOMP-
derived peptides, as predicted using on-line epitope mapping prediction servers.
doi:10.1371/journal.pone.0061139.g001
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Figure 2. MOMP sequence analysis and homology model. (a) Primary sequence of MOMP from C. pneumoniae. The signal sequence is
indicated by an arrow while the four variable segments (VS), interspersed between the five constant domains, are highlighted in bold. (b) Left -
Cartoon representation of the homology model of MOMP from C. pneumoniae, showing the location of the four variable domains (green). VS I, III and
IV are in the barrel while the protease accessible VS II is in the extracellular space. Right - Cysteine residues are highlighted in blue. The N- and C-
termini are coloured red and cyan, respectively.
doi:10.1371/journal.pone.0061139.g002
Transport Mechanism from MOMP in Chlamydophila
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algorithms used). The binding pattern results, based on the
predictions, were used to corroborate those adopted by the docked
poses derived in the docking experiments. The resulting predic-
tions are provided in Tables S3 and S4. Additional tools for the
prediction of peptide binding to HLA DR4 were utilised, however,
fewer methods were available suitably trained to render predic-
tions for I-Ab.
Discussion
Homology Model for MOMP
The genus Chlamydophila is characterised by the presence of a
cysteine rich outer membrane complex of proteins. More than
60% of the Chlamydophila outer membrane is comprised of a major
outer membrane protein, MOMP, which over the years has been
subject of intense research, largely targeted at vaccine develop-
ment. These efforts appear to be driven by two major ideas. First,
community acquired pneumonia is a serious public concern [55]
and second, the consistency of association between Chlamydophila
pneumoniae and cardiovascular events, such as atherosclerosis and
stroke [55], suggest that vaccines against this pathogen may relieve
atherosclerotic plaques [56–58]. However, engineered MOMP-
derived oligopeptides capable of triggering the preferential
elicitation of anti-atherogenic/inflammatory effects represents a
new possibility for drug development.
Cysteine residues in mature MOMP constitute about 2% by
residue. These cysteine residues have been proposed to maintain
membrane integrity of the elementary bodies of the parasite by
forming disulphide linkages with other outer membrane proteins
[14,59]. In addition, MOMP has been asserted to function as an
energy nondependent b-barrel for the transport of solutes across
the hydrophobic lipid cores of the outer membrane. Although
previous work has provided extensive information on the
immunological characteristics of Chlamydophila MOMP, in depth
structural studies have been hampered due to complex protein
aggregation and low level expression in bacteria [60]. Therefore,
the use of computational methods presented herein has contrib-
uted to our current understanding of the complex structural and
functional characteristics of MOMP.
In this study, a plausible homology model for the 40 kDa major
outer membrane protein (MOMP) of Chlamydophila pneumoniae and
molecular docking of MOMP-derived peptides to MHC class II
molecules is presented. The three dimensional model of MOMP is
based on the crystal structure of the fatty acid transporter of E.coli.
The FadL of E.coli shares only 16.9% sequence identity but
39.55% similarity, the latter of which is sufficient for comparative
modelling and hypothesis of protein function.
The MOMP model provides a plausible tertiary structure and
putative functional mechanism for MOMP. The model suggests
that several structurally important cysteine residues are located in
regions predicted to be b-strands with their side chain residues
facing outward, into the membrane bilayer. This lends support to
the notion that MOMP exists in complex disulphide linkages with
Figure 3. Hypothetical transport model of MOMP. The model
shows the relative orientations of the NPA motif (green) and the two
NPS motifs (orange) including the ‘hatch domain’ (yellow) and the
proposed mechanism for solute recognition and transport (dashed
lines). The NPA motif at site 1 is on the extracellular side and may serve
to recognise and orient hydrophilic molecules for transport. The two
NPS motifs are oriented at juxtaposition on the inside of the barrel wall
(site 2 and site 3) to coordinate binding and release of ligands into the
periplasm.
doi:10.1371/journal.pone.0061139.g003
Figure 4. MHC II peptide binding pocket. Structure superposition
of the binding sites of murine I-Ab (PBD code: 1MUJ) and human HLA-
DR4 (PBD code: 2SEB). The binding pockets of the MHCs are designated
P1, P4, P6 and P9. Pocket forming residues of I-Ab are coloured as green
sticks and their corresponding HLA-DR4 residues, as identified by
structural alignments, are coloured as cyan sticks.
doi:10.1371/journal.pone.0061139.g004
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other Chlamydophila outer membrane proteins. Presumably, the
location of these cysteines may not only enhance disulphide
interaction but also provide attractive sites for fatty acid acylation.
Furthermore, the structural rigidity of the membranes of
Chlamydophila, attributed to MOMP, may involve favourable
acylation by fatty acids within the interior of the lipid membrane.
Interestingly, two inner membrane retention signals, namely 49CD
and 56CD, are found within the first 57 residues of the immature
MOMP protein. Although, current literature has supported
sarkosyl insolubility and outer membrane localisation of MOMP
in its native host Chlamydophila, there has been lack of evidence for
the surface expression of MOMP in other expression hosts [61].
It has been suggested that differences in strain variability and
antigenicity lie within four variable segments interspaced between
five constant segments of MOMP. Some literature suggests that
Chlamydophila variable segments are located on the outside of the
outer membrane to enhance antigenicity, however, MOMP of C.
pneumoniae is less immunologically dominant than that of C.
trachomatis [62], which may mirror variation in the surface display
of the antigenic variable segments. According to the homology
model, three of the four variable segments are located in the b-
strand region of the protein, which is presumably buried in the
lipid membrane. Moreover, the second variable segment of
MOMP is likely located in the hydrophobic alpha helix in the
Figure 5. Docking validation. Results of poses derived from validation of the docking procedure showing (a) superposition of the docked pose
from the extracted coordinates of human collagen II peptide and its native crystal state in I-Ab (PBD code: 1MUJ) and (b) superposition of the docked
pose from the extracted coordinates of CLIP and its native crystal state in HLA DR4 (PBD code: 2SEB). The co-crystallised peptides are coloured green
while the complementary docked peptides are shown in cyan.
doi:10.1371/journal.pone.0061139.g005
Figure 6. MOMP-derived peptide docking to I-Ab MCH II. Cartoon representations of the docked poses of four novel MOMP-derived peptides
(MdP1-4, a–d) and the mouse I-Ab MCH II (PDB code 1MUJ). The peptides are coloured by element (green carbon; blue nitrogen; red oxygen). a-
chains of the MHC II are coloured red, b-chains of the MHC II are coloured cyan. Yellow dashes represent potential hydrogen bonding.
doi:10.1371/journal.pone.0061139.g006
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extracellular space (Figure 2). This location lends support to the
experiments by Baehr et al., which demonstrated that variable
segments II and IV are susceptible to protease treatment [63].
A Transport Model for MOMP
The transport model hypothesised for MOMP is supported by
the juxtaposition of two NPS motifs and a single NPA motif
located on the extracellular surface of the protein (Figure3). The
three motifs could represent independent substrate sites, which
coordinate the transport of solutes across the membrane. A
notable characteristic of the NPS motif in the barrel wall is the
inward orientation of the hydrophobic proline ring anchor. The
proposed model suggests that the NPA is positioned in the
extracellular space to facilitate uptake of hydrophilic solutes
whereas, the two NPS motifs may enhance the transport of a wide
variety of hydrophobic solutes. Interestingly, members of the
major intrinsic protein (MIP) family have similar characteristics.
The aquaglyceroporin subgroup of MIPs exhibits the widest
coverage of solute preference and may explain the substitution of
alanine, in the canonical aquaporin NPA motif, by serine [64,65].
The MOMP model presented herein supports the potential for
MOMP to function as both a passive and substrate specific
channel. The barrel orientation of the hydrophobic ring of proline
could presumably anchor substrates at site 2, which could then be
released into the periplasm by NPS residues at site 3. Alternatively,
as in aquaporins, the energetically favoured extracellular NPA
motif at site 1 may orient hydrophilic substrates directly into the
barrel.
MOMP-derived Peptides and Immune Response
It has been demonstrated, that MOMP from C. pneumoniae has
anti-inflammatory, immunomodulatory and anti-atherosclerotic
effects in vivo in C57Bl/6J apoE2/2 mice [20]. This mice strain
has a haplotype for the I-Ab MHC II. This work suggested that
MOMP may play a role in C. pneumoniae modulation of
macrophages and T cell responses, via the inhibition of antigen
presentation and T cell co-stimulation. In an effort to understand
such cell mediated immunomodulation by MOMP, four MOMP-
derived peptides (formerly tested in vivo) were docked into the
peptide binding pockets of mouse MHC II, I-Ab (PDB code
1MUJ) and its human ortholog HLA-DR4 (PDB code 2SEB). The
molecular docking suggests a plausible mechanism through which
MOMP-derived peptides may elicit an immune response via
MHC binding.
This subtle immune evasiveness could be accomplished in at
least one of five ways: i) short lived binding and rapid unloading of
the MHC to avoid identifying bound peptides by TCR, ii)
preferential orientation of short amino acid side chains to create
an unfavourable contact with TCR. Such suboptimal binding
topologies have been reported myelin basic protein/HLA-DR4
complex as a mechanism for escape from negative selection [66],
iii) induction of an overwhelming protective signal by the resulting
MHC-peptide complex, iv) stimulation of the generation of
suppressive/regulatory T cell clones that dampens down inflam-
mation through the synthesis and secretion of anti-inflammatory
cytokines such as IL-10 and TGF beta [12] and, v) competitive
binding of anti-inflammatory MOMP-derived peptides. Such a
mechanism is supported by experiments, showing the effect of a
single amino acid change in collagen II-derived peptide on loss of
T cell activation, demonstrated by [67].
Figure 7. MOMP-derived peptide docking to HLA DR4 MCH II. Cartoon representations of the docked poses of four novel MOMP-derived
peptides (MdP1-4, a–d) and the human HLA DR4 MHC II (PDB code 2SEB). The peptides are coloured by element (green carbon; blue nitrogen; red
oxygen). a-chains of the MHC II are coloured red, b-chains of the MHC II are coloured cyan. Yellow dashes represent potential hydrogen bonding.
doi:10.1371/journal.pone.0061139.g007
Transport Mechanism from MOMP in Chlamydophila
PLOS ONE | www.plosone.org 9 April 2013 | Volume 8 | Issue 4 | e61139
Murine and human MHC alleles were selected for computa-
tional analysis in this study, since I-Ab represents an already
experimentally determined case study in the C57Bl/6J apoE2/2
mice model [12]. Furthermore, I-Ab is bound to a CLIP peptide,
which is a conserved step in the posttranslational processing of
MHC proteins. The HLA-DR4 allele has an identified epitope for
autoimmune disease susceptibility, which could be used to track
the balance of the physiological effects of the docked peptides.
Comparison of the residues, forming the binding pockets of the
two MHCs (Figure 4), illustrate the presence of identical residues
and residues sharing similar aliphatic side chains occupying
strategic positions within the pockets. The highly homologous
autoimmune susceptibility epitope lies between amino acids 67–74
of the b-chain of HLA-DR4. Interaction of bound peptides with
Lysine 71 in the P4 pocket has been suggested to play a role in
rheumatoid arthritis [68,69]. Similarly, key residues within the
epitope that indicate a strong susceptibility to diabetes and
thyroiditis have been identified [70]. Structure based approaches
have been used in the evaluation and design of potential vaccine
candidates with success [71,72]. Confidence in the docking
procedure, as performed in this work on the MOMP-derived
peptides, is supported by replication of the co-crystal structures of
actual ligands in complex with the MHCs of interest (Figure 5).
Three of the MOMP-derived peptides, demonstrated to have anti-
inflammatory properties (peptides 2, 3 and 4), form potential
hydrogen bond interactions with the notably bK71 residue of the
human allele. Expectedly peptide 4, previously suggested to be the
most likely candidate for vaccine development, is involved in two
hydrogen bonds with bK71. However, this does not fully explain
the anti-inflammatory properties of these peptides. It must be
noted that the overall effect of binding and the complex molecular
interaction between the peptides and the MHC must be
consolidated in the variable antigenic display for TCR recognition.
In the case of these docked peptides, extension of the aliphatic side
chains were primarily in the clefts of the binding groove of the
MHC. There appeared to be no significant bulges in the peptide
9-mer sequence, indicative of antigenic display, with the peptide
docking in a buried fashion and each flanking residue slightly
raised. This observation may be a function of the docking
algorithm optimising MHC interactions, in the absence of a TCR
partner, and therefore does not preclude the notion that these
peptides may alter conformation upon subsequent TCR binding.
The docking experiments have indicated a preferred orientation
of each peptide, when docked into the groove of the selected
MHCs. Peptides 1, 2 and 3 were bound to murine MHC in an
anti-parallel orientation compared with the binding pattern
observed in the human allele; whereas peptide 4 bound the two
alleles in a similar fashion. This in part could be due to the greater
aliphatic indices of peptide 4 compared to peptides 1 and 2
(Table 1). Moreover, the formation of peptide-MHC complexes
relies a great deal on the hydrophobic interactions between the
specificity pockets of the MHC and aliphatic side chains of the
peptide. Although this explanation may not account for the reverse
orientations of bound peptide 3 seen in both alleles, flexibility of
the MHC to bind peptides in multiple binding registers has been
demonstrated (Tables S3 and S4), which leads to the possibility of
more than one kind of immune response. This could be the origin
of the mixed immunological response elicited by recombinant
MOMP. Similarly, the same peptides can bind to MHC allotypes
in different registers. The most important criterion for binding is
conservation of the 9-mer binding core and establishment of a
favourable MHC-TCR contact at the complementary determin-
ing regions. The docking results in this work are corroborated by
the complementary immuno-informatic predictions and the
evidence from immunisation studies using the selected MOMP
peptides (Anne-Katrien Stark, PhD Thesis, University of Surrey,
Guildford, United Kingdom, 2011). Immunisation of mice with
peptides 3 and 4 induced CD4+ T cell regulation and a
simultaneous decrease in the total CD4+ T cells compared to
immunisation with peptides 1 and 2. Similarly, peptides 3 and 4
mouse immunization, monitored by elastin and collagen profiles of
atheroma tissues, show that these peptides enhanced formation of
more stable plaques than peptides 1 and 2. Taken together, these
results provide support for the use of novel MOMP-derived
peptides for further development as vaccine candidates for
immune-therapy in the management of atherosclerosis and
possibly other inflammatory diseases. Work is currently underway
to assess the effect of these four peptides on T cell proliferation
in vitro.
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